These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22827830)

  • 1. Structural and functional cardiac changes in myotonic dystrophy type 1: a cardiovascular magnetic resonance study.
    Hermans MC; Faber CG; Bekkers SC; de Die-Smulders CE; Gerrits MM; Merkies IS; Snoep G; Pinto YM; Schalla S
    J Cardiovasc Magn Reson; 2012 Jul; 14(1):48. PubMed ID: 22827830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive evaluation of the relationship between electrical and structural cardiac abnormalities in patients with myotonic dystrophy type 1.
    Chmielewski L; Bietenbeck M; Patrascu A; Rösch S; Sechtem U; Yilmaz A; Florian AR
    Clin Res Cardiol; 2019 Aug; 108(8):857-867. PubMed ID: 30767060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study.
    Petri H; Ahtarovski KA; Vejlstrup N; Vissing J; Witting N; Køber L; Bundgaard H
    J Cardiovasc Magn Reson; 2014 Aug; 16(1):59. PubMed ID: 25086734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and electrical cardiac abnormalities are prevalent in asymptomatic adults with myotonic dystrophy.
    Choudhary P; Nandakumar R; Greig H; Broadhurst P; Dean J; Puranik R; Celermajer DS; Hillis GS
    Heart; 2016 Sep; 102(18):1472-8. PubMed ID: 27164920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical cardiac involvement in myotonic dystrophy manifesting as decreased myocardial Doppler velocities.
    Vinereanu D; Bajaj BP; Fenton-May J; Rogers MT; Mädler CF; Fraser AG
    Neuromuscul Disord; 2004 Mar; 14(3):188-94. PubMed ID: 15036328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial fibrosis by late gadolinium enhancement cardiovascular magnetic resonance in myotonic muscular dystrophy type 1: highly prevalent but not associated with surface conduction abnormality.
    Cardona A; Arnold WD; Kissel JT; Raman SV; Zareba KM
    J Cardiovasc Magn Reson; 2019 May; 21(1):26. PubMed ID: 31046780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early left ventricular structural myocardial alterations and their relationship with functional and electrical properties of the heart in myotonic dystrophy type 1.
    Di Cori A; Bongiorni MG; Zucchelli G; Soldati E; Falorni M; Segreti L; Gemignani C; Siciliano A; Bovenzi FM; Di Bello V
    J Am Soc Echocardiogr; 2009 Oct; 22(10):1173-9. PubMed ID: 19801306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Involvement in Myotonic Dystrophy Type 2 Patients With Preserved Ejection Fraction: Detection by Cardiovascular Magnetic Resonance.
    Schmacht L; Traber J; Grieben U; Utz W; Dieringer MA; Kellman P; Blaszczyk E; von Knobelsdorff-Brenkenhoff F; Spuler S; Schulz-Menger J
    Circ Cardiovasc Imaging; 2016 Jul; 9(7):. PubMed ID: 27363857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach.
    Becker S; Florian A; Patrascu A; Rösch S; Waltenberger J; Sechtem U; Schwab M; Schaeffeler E; Yilmaz A
    J Cardiovasc Magn Reson; 2016 May; 18(1):25. PubMed ID: 27150296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac involvement in a large kindred with myotonic dystrophy. Quantitative assessment and relation to size of CTG repeat expansion.
    Tokgozoglu LS; Ashizawa T; Pacifico A; Armstrong RM; Epstein HF; Zoghbi WA
    JAMA; 1995 Sep; 274(10):813-9. PubMed ID: 7650805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doppler echocardiographic assessment of left ventricular diastolic function in myotonic dystrophy.
    Fragola PV; Caló L; Luzi M; Mammarella A; Antonini G
    Cardiology; 1997; 88(6):498-502. PubMed ID: 9397301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial left ventricular hypertrabeculation in myotonic dystrophy type 1.
    Finsterer J; Stöllberger C; Kopsa W
    Herz; 2003 Aug; 28(5):466-70. PubMed ID: 12928748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left Ventricular Dysfunction and Conduction Disturbances in Patients With Myotonic Muscular Dystrophy Type I and II.
    Tanawuttiwat T; Wagner KR; Tomaselli G; Nazarian S
    JAMA Cardiol; 2017 Feb; 2(2):225-228. PubMed ID: 27829084
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac involvement in patients with myotonic dystrophy: characteristic features of magnetic resonance imaging.
    De Ambroggi L; Raisaro A; Marchianó V; Radice S; Meola G
    Eur Heart J; 1995 Jul; 16(7):1007-10. PubMed ID: 7498193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrocardiogram abnormalities in chronic Chagas cardiomyopathy correlate with scar mass and left ventricular dysfunction as assessed by cardiac magnetic resonance imaging.
    Braggion-Santos MF; Moreira HT; Volpe GJ; Koenigkam-Santos M; Marin-Neto JA; Schmidt A
    J Electrocardiol; 2022; 72():66-71. PubMed ID: 35344746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circumferential myocardial strain in cardiomyopathy with and without left bundle branch block.
    Han Y; Chan J; Haber I; Peters DC; Zimetbaum PJ; Manning WJ; Yeon SB
    J Cardiovasc Magn Reson; 2010 Jan; 12(1):2. PubMed ID: 20047696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular volume fraction is more closely associated with altered regional left ventricular velocities than left ventricular ejection fraction in nonischemic cardiomyopathy.
    Collins J; Sommerville C; Magrath P; Spottiswoode B; Freed BH; Benzuly KH; Gordon R; Vidula H; Lee DC; Yancy C; Carr J; Markl M
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern and prognostic value of cardiac involvement in patients with late-onset pompe disease: a comprehensive cardiovascular magnetic resonance approach.
    Boentert M; Florian A; Dräger B; Young P; Yilmaz A
    J Cardiovasc Magn Reson; 2016 Dec; 18(1):91. PubMed ID: 27931223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ECG quantification of myocardial scar in cardiomyopathy patients with or without conduction defects: correlation with cardiac magnetic resonance and arrhythmogenesis.
    Strauss DG; Selvester RH; Lima JA; Arheden H; Miller JM; Gerstenblith G; Marbán E; Weiss RG; Tomaselli GF; Wagner GS; Wu KC
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):327-36. PubMed ID: 19808427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Mutation Size and Cardiac Involvement in Myotonic Dystrophy Type 1: An Analysis of the DM1-Heart Registry.
    Chong-Nguyen C; Wahbi K; Algalarrondo V; Bécane HM; Radvanyi-Hoffman H; Arnaud P; Furling D; Lazarus A; Bassez G; Béhin A; Fayssoil A; Laforêt P; Stojkovic T; Eymard B; Duboc D
    Circ Cardiovasc Genet; 2017 Jun; 10(3):. PubMed ID: 28611030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.